This was the stock's third consecutive day of losses.

Marketers and their teams doing business as usual, while dabbling with different tools and dashboards, will not be enough to ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance to Beckman Coulter Diagnostics' new DxC 500i Clinical ...

Shares of DXC Technology Co. DXC shed 1.48% to $17.95 Thursday, on what proved to be an all-around rough trading session for ...

The solution can also automate policy administration through AI-driven tools that reduce manual back-office tasks. DXC ...

Beckman Coulter Diagnostics announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry and immunoassay analyzer, ...

DXC Technology's stock has seen a negative 40% return over the past decade, despite the generative AI boom. Explore more details here.

ASHBURN, VA, Feb. 25, 2025 /PRNewswire/ - DXC Technology, (NYSE: DXC), a leading Fortune 500 global technology services provider, has signed an agreement with Skanska AB, a multinational construction ...

ServiceNow and DXC expand their strategic partnership to combine DXC's industry-leading software and expertise with ...

Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the new DxC 500i Clinical Analyzer, an ...

ServiceNow and DXC expand their strategic partnership to combine DXC's industry-leading software and expertise with ServiceNow's AI-enabled platform ASHBURN, Va. and SANTA CLARA, Calif., ...

BREA, Calif., March 10, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry ...